FDA introduces new MedWatch reporting and learning tools
FDA has launched two new tools designed to make it easier for consumers and healthcare professionals to report product information to its MedWatch program.
As it celebrates the 20th anniversary of its MedWatch program, FDA has launched two new tools designed to make it easier for consumers and healthcare professionals to report product information to the agency.
MedWatch allows healthcare professionals and consumers to submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product.
The agency uses that information to make necessary changes to medication labels, to issue product recalls, warning, and safety messages, and to determine how patients receiving products should be monitored.
FDA has introduced a new form that’s more consumer-friendly. It was developed with input from groups such as AARP, Consumers Union, and the National Women's Health Network.
The agency has also introduced a new web-based learning tool, MedWatchLearn, which instructs students, healthcare professionals and consumers on how to correctly complete a report. It also provides examples of properly prepared reports.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
